Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sandham, David A.
70  Ergebnisse:
Personensuche X
?
1

Prostaglandin D2 metabolites activate asthmatic patient-der..:

Carstensen, Saskia ; Gress, Christina ; Erpenbeck, Veit J....
Respiratory Research.  22 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
2

The pharmacology of the prostaglandin D2 receptor 2 (DP2) r..:

Brightling, Chris ; Kulkarni, Swarupa ; Lambrecht, Bart N....
Pulmonary Pharmacology & Therapeutics.  68 (2021)  - p. 102030 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Fevipiprant, a selective prostaglandin D2 receptor 2 antago..:

Hardman, Clare ; Chen, Wentao ; Luo, Jian...
Journal of Allergy and Clinical Immunology.  143 (2019)  6 - p. 2329-2333 , 2019
Link: https://doi.org/10.1016/..
 
?
4

The prostaglandin D2 receptor 2 pathway in asthma: a key pl..:

Domingo, Christian ; Palomares, Oscar ; Sandham, David A...
Respiratory Research.  19 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
5

Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil..:

Shamri, Revital ; Dubois, Gerald ; Erpenbeck, Veit J....
Clinical & Experimental Allergy.  49 (2018)  2 - p. 255-257 , 2018
Link: https://doi.org/10.1111/..
 
?
6

Interactions between β2-Adrenoceptor Ligands and Membrane: ..:

Yan, Si ; Shaw, Duncan E. ; Yang, Linhong...
Journal of Medicinal Chemistry.  60 (2017)  16 - p. 6867-6879 , 2017
Link: https://doi.org/10.1021/..
 
?
7

Correction to "Discovery of Fevipiprant (NVP-QAW039), a Pot..:

Sandham, David A. ; Barker, Lucy ; Brown, Lyndon...
ACS Medicinal Chemistry Letters.  8 (2017)  9 - p. 987-987 , 2017
Link: https://doi.org/10.1021/..
 
?
8

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selecti..:

Sandham, David A. ; Barker, Lucy ; Brown, Lyndon...
ACS Medicinal Chemistry Letters.  8 (2017)  5 - p. 582-586 , 2017
Link: https://doi.org/10.1021/..
 
?
9

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (..:

Erpenbeck, Veit J. ; Vets, Eva ; Gheyle, Lien...
Clinical Pharmacology in Drug Development.  5 (2016)  4 - p. 306-313 , 2016
Link: https://doi.org/10.1002/..
 
?
10

Uncoupling the Structure–Activity Relationships of β2 Adren..:

Dickson, Callum J. ; Hornak, Viktor ; Velez-Vega, Camilo...
Journal of Medicinal Chemistry.  59 (2016)  12 - p. 5780-5789 , 2016
Link: https://doi.org/10.1021/..
 
?
11

Synthetic approaches to site selective deuterium incorporat..:

Sandham, David A. ; Page, Christopher J.
Journal of Labelled Compounds and Radiopharmaceuticals.  57 (2014)  3 - p. 175-177 , 2014
Link: https://doi.org/10.1002/..
 
?
12

Discovery and characterization of NVP-QAV680, a potent and ..:

Sandham, David A. ; Arnold, Nicola ; Aschauer, Heinrich...
Bioorganic & Medicinal Chemistry.  21 (2013)  21 - p. 6582-6591 , 2013
Link: https://doi.org/10.1016/..
 
?
13

An investigation into the structure–activity relationships ..:

Beattie, David ; Beer, David ; Bradley, Michelle E....
Bioorganic & Medicinal Chemistry Letters.  22 (2012)  19 - p. 6280-6285 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Synthesis of useful fragments in drug discovery: 2-Amino-5-..:

Thomson, Christopher G. ; Reilly, John ; Sandham, David A.
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  14 - p. 4281-4283 , 2011
Link: https://doi.org/10.1016/..
 
?
15

7-Azaindole-3-acetic acid derivatives: Potent and selective..:

Sandham, David A. ; Adcock, Claire ; Bala, Kamlesh...
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  16 - p. 4794-4798 , 2009
Link: https://doi.org/10.1016/..
 
1-15